
Based on PubMed | Can head and neck cancer or its treatments lead to blood in urine at night, and how should this symptom be evaluated?
Blood in the urine in people with head and neck cancer is usually due to treatment effects (platinum chemotherapy, immunotherapy) or unrelated urinary conditions; the cancer itself rarely causes it, though metastasis is possible. Any visible hematuria day or night requires prompt evaluation with urinalysis, kidney tests, CT urography, and cystoscopy to rule out infection, stones, treatment toxicity, or urinary-tract cancers.
Blood in the urine (hematuria) can occur in people with head and neck cancer, but it is usually not caused by the tumor in the head or neck itself. It is more commonly related to treatment side effects (especially certain chemotherapies), unrelated urinary problems (like infection or stones), or, less commonly, spread of cancer to the urinary tract. Any visible blood in urine day or night should be taken seriously and evaluated promptly to rule out important causes and to protect kidney and bladder health.
How head and neck cancer treatments can cause hematuria
-
Chemotherapy-related bleeding or kidney irritation: Regimens used for recurrent or metastatic head and neck cancer that include platinum drugs (cisplatin or carboplatin) and fluorouracil sometimes combined with immunotherapy (pembrolizumab) can lead to kidney problems and bleeding in the urinary tract. Patient information for these regimens lists “blood in your urine,” reduced urination, swelling, and other signs of kidney issues as symptoms to watch for. [1] These materials also advise urgent reporting of urine color changes (such as dark or red urine) during treatment. [2] Similar advice is given for carboplatin-based regimens with pembrolizumab. [3] Kidney damage risk and hematuria are emphasized repeatedly in these treatment guides. [4]
-
Radiation-induced cystitis (if pelvic radiation was given): While head and neck radiation itself does not involve the bladder, some people receive radiation to the pelvis for other cancers; in those cases, radiation can inflame the bladder lining and cause bleeding. Radiation-induced cystitis can appear during treatment (acute) or months to years later (late), with gross hematuria in a subset of cases. [5] Chronic radiation cystitis occurs in about 5–10% of pelvic radiation patients, and severe hematuria in 5–8%, often starting on average ~32 months after finishing radiation. [6] Both acute and late radiation bladder injuries are recognized causes of hematuria. [7]
-
General bleeding risk during cancer therapy: Cancer treatments can reduce platelets and affect mucosal linings, which may lead to visible bleeding including red or brown urine. [8]
Can the head and neck cancer itself cause hematuria?
-
Directly, it’s uncommon: Head and neck tumors are not anatomically connected to the urinary tract. Classic symptom lists for head and neck cancers focus on mouth, throat, and neck findings not blood in urine. [9] [10]
-
Rarely, through metastasis: Spread of squamous cell carcinoma to the kidney or bladder is unusual but reported across cancer types; when it happens, hematuria can be an initial clue to urinary-tract involvement. [11] In general, gross hematuria in adults is treated as a possible sign of urologic malignancy until proven otherwise, so a complete urologic workup is recommended. [12]
Other common causes to consider
Even in people undergoing cancer care, hematuria often has causes unrelated to the original tumor:
- Urinary tract infection
- Kidney or bladder stones
- Benign prostate enlargement (in men)
- Glomerular (kidney) disease
- Primary urinary-tract cancers (kidney, ureter, or bladder)
Because the list includes serious conditions, a structured evaluation is important for anyone with visible blood in urine. [13] [14]
How hematuria should be evaluated
A methodical, step-by-step workup helps find the cause efficiently and safely.
1) History and physical
- Timing (only at night vs all day), pain/burning, clots, recent strenuous exercise, trauma, medications (blood thinners), and treatment timeline (recent chemo cycles or immunotherapy) are relevant.
- Clinicians will also ask about prior radiation therapy and occupational exposures. [15]
2) Urinalysis and basic labs
- Urinalysis with microscopy to confirm red blood cells and look for infection or protein.
- Urine culture if infection is suspected.
- Kidney function tests (creatinine, eGFR), especially if on cisplatin/carboplatin.
- Consider urine cytology in select cases.
3) Imaging of the upper urinary tract
- CT urography is often the preferred imaging to evaluate kidneys and ureters for stones, tumors, or bleeding sources. [12] Imaging helps localize the source when the cause is not evident on labs alone. [14]
4) Cystoscopy for the lower urinary tract
- Direct visualization of the bladder and urethra with a scope is a key part of the evaluation for visible hematuria. [12] Cystoscopy is particularly informative during active bleeding to identify lesions or inflamed tissue. [16]
5) Additional tests when needed
- If no cause is found and kidney (glomerular) disease is suspected, nephrology input may be needed.
- Flexible ureteroscopy can be used when upper-tract lesions remain unexplained on imaging. This can complete the exploration if CT and cystoscopy are inconclusive. [12]
Bottom line on evaluation: Once hematuria is confirmed, guidelines support a comprehensive assessment including history, exam, lab tests, upper-tract imaging, and cystoscopy to avoid missing treatable or serious causes. [13] [12] [14]
What to do right now
-
If you are currently on cisplatin, carboplatin, fluorouracil, or pembrolizumab, or recently received them, report any red, tea-colored, or brown urine to your oncology team promptly, since this can signal kidney irritation or treatment-related bleeding. [1] Care teams often adjust hydration and monitor kidney tests during these regimens to protect kidney function. [2] Educational materials emphasize seeking care for urine changes without delay. [4]
-
If you ever had radiation to the pelvis (for any reason), late bladder bleeding can occur months to years later and merits urology evaluation. [6] [5] [7]
-
Regardless of treatment status, visible blood in the urine should prompt a full hematuria workup this helps distinguish benign issues like infection from more serious problems, including urinary-tract cancers. [12] [13]
Frequently asked questions
-
Is night-time hematuria different from daytime hematuria?
Not really bleeding that appears mainly at night could reflect urine concentration, hydration patterns, or positional factors, but the presence of any visible blood still indicates the same need for evaluation and should not be ignored. [13] -
Can immunotherapy cause hematuria?
Immune checkpoint inhibitors (like pembrolizumab) can trigger inflammation in various organs, including kidneys (interstitial nephritis) or bladder, which may lead to blood in the urine. These effects are monitored closely during combination regimens used in head and neck cancer. [1] [3]
Key takeaways
- Head and neck cancer treatments particularly platinum-based chemotherapy with or without immunotherapy can cause hematuria and kidney issues that need prompt attention. [1] [3] [4] [2]
- Radiation to the pelvis (if applicable) can lead to radiation cystitis and delayed-onset hematuria. [6] [5] [7]
- Visible blood in urine should be evaluated with urinalysis, kidney tests, CT urography, and cystoscopy to rule out infection, stones, treatment toxicity, and urinary cancers. [13] [12] [14] [16]
- Even though head and neck cancer itself rarely causes hematuria directly, the symptom should always be taken seriously and investigated. [9] [10]
Related Questions
Sources
- 1.^abcdPatient information - Head and neck cancer recurrent or metastatic - Cisplatin, fluorouracil and pembrolizumab(eviq.org.au)
- 2.^abcPatient information - Head and neck cancer recurrent or metastatic - Cisplatin, fluorouracil and pembrolizumab(eviq.org.au)
- 3.^abcPatient information - Head and neck cancer recurrent or metastatic - Carboplatin, fluorouracil and pembrolizumab(eviq.org.au)
- 4.^abcPatient information - Head and neck cancer recurrent or metastatic - Carboplatin, fluorouracil and pembrolizumab(eviq.org.au)
- 5.^abc1764-Radiation-induced cystitis | eviQ(eviq.org.au)
- 6.^abc1297-Haemorrhagic cystitis | eviQ(eviq.org.au)
- 7.^abc1297-Haemorrhagic cystitis | eviQ(eviq.org.au)
- 8.^↑Sangrado durante el tratamiento para el cáncer: MedlinePlus enciclopedia médica(medlineplus.gov)
- 9.^abHead and neck cancers - Symptoms and causes(mayoclinic.org)
- 10.^abHead and neck cancers - Symptoms and causes(mayoclinic.org)
- 11.^↑Haematuria as an uncommon initial presenting symptom of metastatic squamous cell carcinoma (SCC) to kidney.(pubmed.ncbi.nlm.nih.gov)
- 12.^abcdefg[How to explore ... a gross hematuria].(pubmed.ncbi.nlm.nih.gov)
- 13.^abcdeAssessment of hematuria.(pubmed.ncbi.nlm.nih.gov)
- 14.^abcdWork-up of hematuria.(pubmed.ncbi.nlm.nih.gov)
- 15.^↑Blood in urine (hematuria) - Diagnosis and treatment(mayoclinic.org)
- 16.^abDetermining the cause of hematuria.(pubmed.ncbi.nlm.nih.gov)
Important Notice: This information is provided for educational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any medical decisions.


